TSX lower as gold rally takes a breather
WILMINGTON - DuPont de Nemours, Inc. (NYSE:DD), a $32.6 billion chemical giant with a strong track record of maintaining dividends for 55 consecutive years, announced Wednesday the final results of its exchange offers for three series of outstanding notes, with varying participation rates across the different series. According to InvestingPro data, the company maintains a GOOD financial health score and offers investors a 2.11% dividend yield.
The exchange offers, which expired on September 30, saw holders of $1.58 billion in 4.725% Notes due 2028 participate, representing 70.42% of the outstanding principal amount. For the 5.319% Notes due 2038 and 5.419% Notes due 2048, participation was lower at 22.60% ($226 million) and 13.71% ($295 million) respectively.
DuPont received sufficient consents to adopt proposed amendments to the indenture for the 2028 Notes, but not for the 2038 or 2048 Notes. The company waived the minimum tender condition for these latter series and accepted all tendered notes.
For each $1,000 principal amount of existing notes tendered, eligible holders will receive $1,000 principal amount of new notes of the applicable series and $2.50 in cash. The new notes will maintain the same interest rate, payment dates, maturity date, and optional redemption provisions as the existing notes.
The settlement date is expected to be October 2, 2025. The new notes have not been registered with the Securities and Exchange Commission and may not be offered or sold in the United States except under exemption from registration requirements.
In connection with its planned Electronics business separation targeted for November 1, DuPont expects to redeem additional 2028 Notes following the completion of that transaction.
This article is based on a press release statement from DuPont.
In other recent news, DuPont has announced significant developments that investors should note. The company is set to spin off its electronics business, Qnity Electronics, on November 1, 2025, with October 22, 2025, marked as the record date for distribution. This strategic move has garnered positive reactions from analysts, with UBS maintaining a Buy rating and Wells Fargo reinstating coverage with an Overweight rating, citing potential value unlock for shareholders. Meanwhile, BMO Capital slightly lowered its price target for DuPont to $104.00 but maintained an Outperform rating, indicating continued confidence in the company’s prospects.
In addition to the spin-off, DuPont has signed an agreement to acquire Sinochem (Ningbo) RO Memtech Co., Ltd., a Chinese membrane manufacturer. This acquisition aims to expand DuPont’s reverse osmosis manufacturing capabilities in China and the Asia Pacific region, adding a third production facility to its global network. The new facility will produce FilmTec reverse osmosis elements, enhancing DuPont’s footprint in industrial water purification and reuse applications. These recent developments highlight DuPont’s strategic efforts to strengthen its market position and provide growth opportunities for investors.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.